Skip to content

Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc.

Petition for certiorari denied on October 6, 2014

Docket No. Op. Below Argument Opinion Vote Author Term
13-1251 Fed. Cir. N/A N/A N/A N/A OT 2014

Issue: Whether the statutory bar for "public use" of an invention under 35 U.S.C. § 102(b) (2006) (pre-America Invents Act) (current version at 35 U.S.C. § 102(a)(1)(2012)) broadly bars a patent when an innovator company allows any public access to its invention even if the invention is not actually used in public for its intended purpose.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
04/16/2014Petition for a writ of certiorari filed. (Response due May 19, 2014)
05/15/2014Order extending time to file response to petition to and including June 18, 2014, for all respondents.
06/18/2014Brief of respondent Teva Pharmaceuticals USA, Inc., et al. in opposition filed.
07/02/2014DISTRIBUTED for Conference of September 29, 2014.
10/06/2014Petition DENIED.